Both in Biotechnology
Passage Bio vs Scilex Holding
Over the past year PASG returned −48.4% and SCLX returned −90.8%; their daily moves had a correlation of 0.04.
PASG −48.4% SCLX −90.8%Growth of $1, one year, split-adjusted
| Metric | PASG | SCLX |
|---|---|---|
| Price | $3.46 | $1.70 |
| Market cap | $11.1M | $12.0M |
| Today | −1.42% | −7.10% |
| 1 month | −10.2% | −51.3% |
| 6 months | −15.2% | −78.9% |
| Year to date | −70.7% | −86.1% |
| 1 year | −47.9% | −91.4% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | — | 51.9% |
| Net margin | — | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $24.2M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 70.2% |
| Short % of float | 2.4% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).